Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PDS | NE |
|---|---|---|
| Price | $83.56 | $40.97 |
| Change today | ▼ 1.37% | ▼ 1.16% |
| Market cap | $1.05B | $6.54B |
| Return, 3 months | +3.6% | +6.4% |
| Return, year to date | +16.2% | +49.8% |
| Return, 1 year | +46.6% | +45.1% |
| P/E (TTM) | -50.5 | 43.6 |
| P/B | 0.9 | 1.5 |
| P/E percentile vs own 5y | 8th | 97th |
| Dividend yield | – | 4.88% |
| Revenue growth (YoY, latest qtr) | +11.4% | -15.2% |
| Net profit growth (YoY) | -105.4% | -185.6% |
| Gross margin | 82.5% | 16.5% |
| Operating margin | 3.3% | 12.6% |
| Net margin | -1.7% | 4.9% |
| Return on equity | -2.0% | 3.3% |
| Analyst target vs. price | +26.3% | +17.2% |
| Analyst buy share | 83% | 40% |
| RSI (14) | 47 | 39 |
| 30-day volatility | 37.2% | 37.0% |
| Max drawdown, 1 year | -28.3% | -31.1% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
